TY  - GEN
AU  - Engstrom,Lars D
AU  - Aranda,Ruth
AU  - Lee,Matthew
AU  - Tovar,Elizabeth A
AU  - Essenburg,Curt J
AU  - Madaj,Zachary
AU  - Chiang,Harrah
AU  - Briere,David
AU  - Hallin,Jill
AU  - Lopez-Casas,Pedro P
AU  - Baños,Natalia
AU  - Menendez,Camino
AU  - Hidalgo,Manuel
AU  - Tassell,Vanessa
AU  - Chao,Richard
AU  - Chudova,Darya I
AU  - Lanman,Richard B
AU  - Olson,Peter
AU  - Bazhenova,Lyudmilla
AU  - Patel,Sandip Pravin
AU  - Graveel,Carrie
AU  - Nishino,Mizuki
AU  - Shapiro,Geoffrey I
AU  - Peled,Nir
AU  - Awad,Mark M
AU  - Jänne,Pasi A
AU  - Christensen,James G
TI  - Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring 
SN  - 1557-3265
PY  - 2018///0723
KW  - Adult
KW  - Aged
KW  - Animals
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Benzeneacetamides
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Crizotinib
KW  - Drug Resistance, Neoplasm
KW  - drug effects
KW  - Exons
KW  - genetics
KW  - Female
KW  - Humans
KW  - Liver Neoplasms
KW  - Male
KW  - Mice
KW  - Middle Aged
KW  - Mutation
KW  - Protein Kinase Inhibitors
KW  - administration & dosage
KW  - Proto-Oncogene Proteins c-met
KW  - antagonists & inhibitors
KW  - Pyrazoles
KW  - Pyridines
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-17-1192
ER  -